Cargando…
A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada
This study models the impact of using two different types of high-risk (HR) human papillomavirus (HPV) tests: mRNA (Aptima) and DNA (Hybrid Capture 2) as part of a hypothetical primary HPV screening program in Ontario, Canada. Outcomes were the costs of the screening program, and number of colposcop...
Autores principales: | Weston, Georgie, Dombrowski, Caroline, Steben, Marc, Popadiuk, Catherine, Bentley, James, Adams, Elisabeth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334715/ https://www.ncbi.nlm.nih.gov/pubmed/34381664 http://dx.doi.org/10.1016/j.pmedr.2021.101448 |
Ejemplares similares
-
Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
por: Dombrowski, Caroline A., et al.
Publicado: (2022) -
Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation
por: Weston, Georgie, et al.
Publicado: (2020) -
Determinants of HPV vaccine awareness and healthcare providers' discussion of HPV vaccine among females
por: Ojinnaka, Chinedum O., et al.
Publicado: (2017) -
Muslim immigrant women’s views on cervical cancer screening and HPV self-sampling in Ontario, Canada
por: Vahabi, Mandana, et al.
Publicado: (2016) -
Catholic bioethical perspectives on Ontario’s HPV vaccination
por: Kirkwood, Ken
Publicado: (2008)